Selectis Health, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Lance Baller. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Lance Baller has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GBCS / Selectis Health, Inc. CEO, Director 161,965
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Lance Baller. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GBCS / Selectis Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GBCS / Selectis Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-10-06 GBCS Baller Lance 100 5.8000 100 5.8000 580 0 5.8000 0 0.00
2022-10-06 GBCS Baller Lance 400 6.0000 400 6.0000 2,400
2016-01-07 GBCS Baller Lance 7,600 0.7800 760 7.8000 5,928
2016-01-06 GBCS Baller Lance 5,000 0.7500 500 7.5000 3,750
2016-01-06 GBCS Baller Lance 12,400 0.7800 1,240 7.8000 9,672
2016-01-05 GBCS Baller Lance 26,600 0.7000 2,660 7.0000 18,620
2015-12-22 GBCS Baller Lance 15,000 0.6500 1,500 6.5000 9,750
2015-12-21 GBCS Baller Lance 40 0.6500 4 6.5000 26
2015-12-17 GBCS Baller Lance 8,300 0.6500 830 6.5000 5,395
2015-09-10 GBCS Baller Lance 39,000 0.8500 3,900 8.5000 33,150
2015-09-09 GBCS Baller Lance 9,000 0.9000 900 9.0000 8,100

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GBCS / Selectis Health, Inc. Insider Trades
Insider Sales GBCS / Selectis Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GBCS / Selectis Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GBCS / Selectis Health, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Lance Baller as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-10-07 2022-10-06 4 GBCS SELECTIS HEALTH, INC.
Common Stock
P - Purchase 400 161,965 0.25 6.00 2,400 971,790
2022-10-07 2022-10-06 4 GBCS SELECTIS HEALTH, INC.
Common Stock
P - Purchase 100 161,565 0.06 5.80 580 937,077
2022-04-07 2022-03-30 4 GBCS SELECTIS HEALTH, INC.
Common Stock Options
A - Award 100,000 100,000 7.00 700,000 700,000
2022-01-13 2021-12-31 4 GBCS SELECTIS HEALTH, INC.
Common Stock
C - Conversion 20,000 46,616 75.14 5.00 100,000 233,080
2021-09-09 2021-08-20 4 GBCS SELECTIS HEALTH, INC.
Common Stock
A - Award 66,667 66,667 0.50 33,334 33,334
2021-09-09 2021-08-20 4 GBCS SELECTIS HEALTH, INC.
Common Stock
A - Award 100,000 729,335 15.89 0.50 50,000 364,668
2019-03-07 2019-03-05 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 90,909 1,614,654 5.97
2018-09-10 2018-09-06 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 250,000 1,523,745 19.63
2018-03-28 2018-01-23 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 93,750 1,273,745 7.94
2017-09-11 2017-06-21 4/A GBCS GLOBAL HEALTHCARE REIT, INC.
Warrants
P - Purchase 100,000 200,000 100.00 0.75 75,000 150,000
2017-09-11 2017-06-21 4/A GBCS GLOBAL HEALTHCARE REIT, INC.
Warrants
P - Purchase 100,000 200,000 100.00 0.75 75,000 150,000
2017-08-14 2017-08-07 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 168,889 1,179,995 16.70
2017-08-14 2017-08-07 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 84,444 1,011,106 9.11
2017-04-21 2017-04-21 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 29,269 926,662 3.26
2017-04-21 2017-04-21 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 86,364 897,393 10.65
2017-03-15 2017-03-15 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 174,000 811,029 27.31
2017-03-14 2017-01-12 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 52,632 637,029 9.01
2016-12-23 2016-11-25 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Warrants
A - Award 100,000 100,000 0.75 75,000 75,000
2016-12-23 2016-11-25 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Warrants
A - Award 100,000 100,000 0.75 75,000 75,000
2016-08-09 2016-08-05 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 250,000 584,397 74.76
2016-01-14 2016-01-14 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 45,455 334,397 15.73
2016-01-07 2016-01-07 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 7,600 629,275 1.22 0.78 5,928 490,834
2016-01-07 2016-01-06 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 12,400 621,675 2.04 0.78 9,672 484,906
2016-01-07 2016-01-06 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 5,000 609,275 0.83 0.75 3,750 456,956
2016-01-07 2016-01-05 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 26,600 604,275 4.60 0.70 18,620 422,992
2015-12-24 2015-12-22 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 15,000 577,675 2.67 0.65 9,750 375,489
2015-12-24 2015-12-21 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 40 562,675 0.01 0.65 26 365,739
2015-12-24 2015-12-17 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 8,300 562,635 1.50 0.65 5,395 365,713
2015-12-24 2013-09-30 4 GBCS GLOBAL HEALTHCARE REIT, INC.
B Warrants
A - Award 106,500 106,500
2015-09-11 2015-09-10 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
P - Purchase 39,000 554,335 7.57 0.85 33,150 471,185
2015-09-11 2015-09-09 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
P - Purchase 9,000 288,942 3.21 0.90 8,100 260,048
2015-09-11 2015-07-23 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
A - Award 17,442 279,942 6.64
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
1,559,326
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
1,310,147
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
1,306,491
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
1,559,326
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
1,310,147
2015-07-07 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
1,306,491
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)